Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

Tue, 14th Jul 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

CREDIT SUISSE RAISES HALMA PRICE TARGET TO 2530 (2030) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES JOHNSON MATTHEY TARGET TO 3500 (3400) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES CRODA INTERNATIONAL TARGET TO 5100 (4500) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES FLUTTER PRICE TARGET TO 10500 (10000) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES SMITHS PRICE TARGET TO 1530 (1300) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS STANDARD CHARTERED PRICE TARGET TO 690 (730) PENCE - 'BUY'

----------

GOLDMAN CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 195 (215) PENCE - 'BUY'

----------

GOLDMAN CUTS LLOYDS BANKING PRICE TARGET TO 29 (32) PENCE - 'SELL'

----------

GOLDMAN CUTS BARCLAYS PRICE TARGET TO 135 (150) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS HSBC TO 'BUY' ('CONVICTION BUY LIST') - PRICE TARGET 565 (695) PENCE

----------

DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 135 (208) PENCE - 'BUY'

----------

DEUTSCHE BANK RESUMES STANDARD CHARTERED WITH 'HOLD' - TARGET 415 PENCE

----------

DEUTSCHE BANK RESUMES RBS WITH 'SELL' - TARGET 100 PENCE

----------

DEUTSCHE BANK REINITIATES LLOYDS BANKING WITH 'HOLD' - PRICE TARGET 34 PENCE

----------

DEUTSCHE BANK REINITIATES HSBC WITH 'SELL' - PRICE TARGET 335 PENCE

----------

JPMORGAN RAISES LEGAL & GENERAL TARGET TO 202 (200) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

DEUTSCHE BANK RAISES G4S TO 'BUY' ('HOLD') - TARGET 160 (140) PENCE

----------

DEUTSCHE BANK RESUMES VIRGIN MONEY WITH 'BUY' - TARGET 105 PENCE

----------

JPMORGAN CUTS JOHN WOOD PRICE TARGET TO 400 (590) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES AVON RUBBER PRICE TARGET TO 3510 (2435) PENCE - 'HOLD'

----------

BERENBERG CUTS PRIMARY HEALTH PROPERTIES TO 'HOLD' ('BUY') - TARGET 155 (150) PENCE

----------

BERENBERG CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 200 (190) PENCE

----------

BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 200 (210) PENCE - 'OVERWEIGHT'

----------

RBC RAISES BODYCOTE PRICE TARGET TO 710 (650) PENCE - 'OUTPERFORM'

----------

RBC RAISES MORGAN ADVANCED TO SECTOR PERFORM ('UNDERPERFORM') - TARGET 275 (250) PENCE

----------

RBC CUTS ROTORK TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 275 (265) PENCE

----------

RBC RAISES IMI TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1140 (1000) PENCE

----------

GOLDMAN CUTS VIRGIN MONEY PRICE TARGET TO 95 (100) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING TARGET TO 180 (170) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SPIRENT PRICE TARGET TO 325 (290) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RESUMES MITIE GROUP WITH 'HOLD' - TARGET 43 PENCE

----------

BERENBERG RAISES CONNECT GROUP TO 'BUY' ('HOLD') - TARGET 27 (15) PENCE

----------

DEUTSCHE BANK CUTS FORTERRA PRICE TARGET TO 234 (340) PENCE - 'BUY'

----------

BERNSTEIN CUTS BOOHOO PRICE TARGET TO 350 (480) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS KENMARE RESOURCES PRICE TARGET TO 370 (380) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 1300 (1500) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS HUNTING PRICE TARGET TO 210 (460) PENCE - 'NEUTRAL'

----------

RBC RAISES RESTAURANT GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 80 (70) PENCE

----------

GOLDMAN CUTS BANK OF IRELAND PRICE TARGET TO 1.75 (2) EUR - 'NEUTRAL'

----------

GOLDMAN CUTS AIB GROUP PRICE TARGET TO 1.80 (2.20) EUR - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Sep 2021 09:53

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Read more
9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 14:28

Clinigen signs UK distribution deal for Paion hospital drugs

Clinigen signs UK distribution deal for Paion hospital drugs

Read more
1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

Read more
1 Sep 2021 09:12

Allen out, Schnee in as Cliningen board chairman

(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.

Read more
25 Aug 2021 20:39

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

Read more
25 Aug 2021 07:34

Clinigen CFO Nick Keher steps down

(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".

Read more
5 Aug 2021 10:45

Clinigen inks partnership agreement with Eyevance Pharmaceuticals

(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.

Read more
5 Aug 2021 10:42

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Read more
3 Aug 2021 15:29

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

Read more
21 Jul 2021 14:44

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

Read more
14 Jul 2021 13:23

Wednesday broker round-up

(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.

Read more
13 Jul 2021 10:43

Clinigen expects annual revenue rise in transitional year

Clinigen expects annual revenue rise in transitional year

Read more
13 Jul 2021 09:36

Clinigen ends year in line with expectations

(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.

Read more
11 Jul 2021 18:55

Sunday share tips: Clinigen, UK companies

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.